← Back to Search

Virtual Reality Education for Cancer

N/A

Waitlist Available

Led By Adam Mueller, MD

Research Sponsored by Thomas Jefferson University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and after mri scan at time of planning scan

Awards & highlights

Study Summary

This trial explores if using VR headsets can help patients understand their disease and reduce anxiety about treatment. 3D images may help the patient visualize their tumor & Linac better.

Who is the study for?

This trial is for adults over 18 with a confirmed diagnosis of blood cancer or tumors, who are scheduled to receive radiation treatment using an MRI linear accelerator. It's not suitable for children, those who don't speak English, or individuals unable to use a VR headset.Check my eligibility

What is being tested?

The study tests whether virtual reality can help patients understand their condition and reduce anxiety about treatments. Participants will use VR headsets to view 3D images of their tumor and the MRI Linac machine used in their therapy.See study design

What are the potential side effects?

There may be minimal side effects from this non-invasive intervention; however, some participants might experience discomfort or dizziness from using the VR headset.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and at first on treatment visit (after starting radiation)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and at first on treatment visit (after starting radiation)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and at first on treatment visit (after starting radiation) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Increase in composite knowledge questionnaire score

Secondary outcome measures

General anxiety

Anxiety

Plan review understanding

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Cohort II (virtual reality)Experimental Treatment4 Interventions

Patients receive image review using virtual reality stimulation on study. Patients also view MRI treatment room using virtual reality stimulation. Patients undergo MRI and CT imaging at screening and on study

Group II: Cohort I (standard imaging)Active Control4 Interventions

Patients receive 2D image review using standard computer screen on study. Patients undergo MRI and CT imaging at screening and on study

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Computed Tomography

2017

Completed Phase 2

~2720

Magnetic Resonance Imaging

2017

Completed Phase 3

~1190

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Thomas Jefferson UniversityLead Sponsor

445 Previous Clinical Trials

145,714 Total Patients Enrolled

Adam Mueller, MDPrincipal InvestigatorThomas Jefferson University

2 Previous Clinical Trials

91 Total Patients Enrolled

Media Library

Cohort II (virtual reality) Clinical Trial Eligibility Overview. Trial Name: NCT05600556 — N/A

Blood Cancers Research Study Groups: Cohort I (standard imaging), Cohort II (virtual reality)

Blood Cancers Clinical Trial 2023: Cohort II (virtual reality) Highlights & Side Effects. Trial Name: NCT05600556 — N/A

Cohort II (virtual reality) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05600556 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitment efforts underway to enlist participants in this experiment?

"According to clinicaltrials.gov, this medical experiment has ceased its patient recruitment phase; the study was initially submitted on December 1st of 2022 but last edited on October 26th 2022. However, there are still 2425 other studies currently enrolling patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Virtual Reality for the Improvement of Patients Understanding of Disease and Treatment (MRgRT)

2024. "Virtual Reality for the Improvement of Patients Understanding of Disease and Treatment (MRgRT)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05600556.